Drugs / GlaucoSelect
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02984813 | Apr 2016 → Jan 2017 | diabetic retinopathy, open-angle glaucoma | The New York Eye & Ear Infirmary | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GlaucoSelect | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02984813 ↗ |
| Route | Oral | “2 pills once daily in the morning for 3 months” NCT02984813 ↗ |